• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个发生 SARS-CoV-2 超级传播事件的社区中进行病死率影响和血清阳性率调查分析。

Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event.

机构信息

Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.

German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany.

出版信息

Sci Rep. 2023 Apr 3;13(1):5440. doi: 10.1038/s41598-023-32441-7.

DOI:10.1038/s41598-023-32441-7
PMID:37012282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10069345/
Abstract

There is an ongoing debate on the COVID-19 infection fatality rate (IFR) and the impact of COVID-19 on overall population mortality. Here, we addressed these issues in a community in Germany with a major superspreader event analyzing deaths over time and auditing death certificates in the community.18 deaths that occurred within the first six months of the pandemic had a positive test for SARS-CoV-2. Six out of 18 deaths had non-COVID-19 related causes of death (COD). Individuals with COVID-19 COD typically died of respiratory failure (75%) and tended to have fewer reported comorbidities (p = 0.029). Duration between first confirmed infection and death was negatively associated with COVID-19 being COD (p = 0.04). Repeated seroprevalence essays in a cross-sectional epidemiological study showed modest increases in seroprevalence over time, and substantial seroreversion (30%). IFR estimates accordingly varied depending on COVID-19 death attribution. Careful ascertainment of COVID-19 deaths is important in understanding the impact of the pandemic.

摘要

关于 COVID-19 感染死亡率 (IFR) 和 COVID-19 对总体人口死亡率的影响,目前存在争议。在这里,我们通过分析一段时间内的死亡人数并审核社区内的死亡证明,研究了德国一个有重大超级传播事件的社区中的这些问题。在大流行的前六个月内发生的 18 例死亡病例的 SARS-CoV-2 检测结果呈阳性。18 例死亡中有 6 例与 COVID-19 无关(非 COVID-19 相关死因)。患有 COVID-19 COD 的个体通常死于呼吸衰竭(75%),且报告的合并症较少(p=0.029)。首次确诊感染与死亡之间的时间间隔与 COVID-19 作为 COD 呈负相关(p=0.04)。在一项横断面流行病学研究中反复进行血清学检测表明,血清阳性率随时间呈适度增加,且大量血清学转化率(30%)。因此,IFR 估计值取决于 COVID-19 死亡归因的不同而有所差异。仔细确定 COVID-19 死亡病例对于了解大流行的影响很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/0b34c5d88219/41598_2023_32441_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/3d78b474bbc1/41598_2023_32441_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/ded016a7a465/41598_2023_32441_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/5cef0f12ba15/41598_2023_32441_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/08e2fb713207/41598_2023_32441_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/0b34c5d88219/41598_2023_32441_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/3d78b474bbc1/41598_2023_32441_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/ded016a7a465/41598_2023_32441_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/5cef0f12ba15/41598_2023_32441_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/08e2fb713207/41598_2023_32441_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c639/10070407/0b34c5d88219/41598_2023_32441_Fig5_HTML.jpg

相似文献

1
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event.在一个发生 SARS-CoV-2 超级传播事件的社区中进行病死率影响和血清阳性率调查分析。
Sci Rep. 2023 Apr 3;13(1):5440. doi: 10.1038/s41598-023-32441-7.
2
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.COVID-19 大流行第一年期间挪威人群中 SARS-CoV-2 血清流行率和感染病死率的趋势。
Influenza Other Respir Viruses. 2022 Mar;16(2):204-212. doi: 10.1111/irv.12932. Epub 2021 Nov 9.
3
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.使用潜在类别分析估计和确定 SARS-CoV-2 血清流行率和感染病死率:2020 年春季德国受灾最严重的县特赖恩施泰因的基于人群的研究。
Viruses. 2021 Jun 10;13(6):1118. doi: 10.3390/v13061118.
4
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
5
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.利用血清流行率调查估计美国 SARS-CoV-2 感染、有症状感染、住院和死亡人数。
JAMA Netw Open. 2021 Jan 4;4(1):e2033706. doi: 10.1001/jamanetworkopen.2020.33706.
6
SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.墨西哥首轮疫情过后的 SARS-CoV-2 感染病死率。
Int J Epidemiol. 2022 May 9;51(2):429-439. doi: 10.1093/ije/dyac015.
7
COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.俄罗斯圣彼得堡的 COVID-19 疫情:结合基于人群的血清学研究和监测数据。
PLoS One. 2022 Jun 15;17(6):e0266945. doi: 10.1371/journal.pone.0266945. eCollection 2022.
8
Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.估算德国 COVID-19 大流行期间的有效感染病死率。
BMC Public Health. 2021 Jun 5;21(1):1073. doi: 10.1186/s12889-021-11127-7.
9
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.南非豪登省估计的 SARS-CoV-2 感染率和病死率:一项基于人群的血清流行病学调查。
Int J Epidemiol. 2022 May 9;51(2):404-417. doi: 10.1093/ije/dyab217.
10
Infection fatality rate of COVID-19 in community-dwelling elderly populations.社区居住老年人中 COVID-19 的感染病死率。
Eur J Epidemiol. 2022 Mar;37(3):235-249. doi: 10.1007/s10654-022-00853-w. Epub 2022 Mar 20.

引用本文的文献

1
Seroepidemiological investigation of SARS-CoV-2 infection and risk factors in Indonesia before mass COVID-19 vaccination.印度尼西亚大规模新冠疫苗接种前新冠病毒2型感染及危险因素的血清流行病学调查
Narra J. 2025 Apr;5(1):e1957. doi: 10.52225/narra.v5i1.1957. Epub 2025 Mar 24.
2
Flaws and uncertainties in pandemic global excess death calculations.大流行期间全球超额死亡计算中的缺陷和不确定性。
Eur J Clin Invest. 2023 Aug;53(8):e14008. doi: 10.1111/eci.14008. Epub 2023 Apr 24.
3
The end of the COVID-19 pandemic.新冠大流行的终结。

本文引用的文献

1
The WHO estimates of excess mortality associated with the COVID-19 pandemic.世界卫生组织对 COVID-19 大流行相关超额死亡人数的估计。
Nature. 2023 Jan;613(7942):130-137. doi: 10.1038/s41586-022-05522-2. Epub 2022 Dec 14.
2
COVID-19 and excess mortality in Russia: Regional estimates of life expectancy losses in 2020 and excess deaths in 2021.COVID-19 和俄罗斯的超额死亡率:2020 年预期寿命损失和 2021 年超额死亡的区域估计。
PLoS One. 2022 Nov 2;17(11):e0275967. doi: 10.1371/journal.pone.0275967. eCollection 2022.
3
Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020-2021: A death certificates study in a middle-income country.
Eur J Clin Invest. 2022 Jun;52(6):e13782. doi: 10.1111/eci.13782. Epub 2022 Apr 5.
4
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies.影响非随机研究中 COVID-19 疫苗有效性估计的因素。
BMJ Evid Based Med. 2022 Dec;27(6):324-329. doi: 10.1136/bmjebm-2021-111901. Epub 2022 Mar 25.
2020 - 2021年新冠疫情期间墨西哥超额死亡率的主要原因:一项针对中等收入国家的死亡证明研究
Lancet Reg Health Am. 2022 Sep;13:100303. doi: 10.1016/j.lana.2022.100303. Epub 2022 Jun 24.
4
Excess Mortality during the COVID-19 Pandemic in Cities of Chile: Magnitude, Inequalities, and Urban Determinants.新冠大流行期间智利城市的超额死亡率:规模、不平等和城市决定因素。
J Urban Health. 2022 Oct;99(5):922-935. doi: 10.1007/s11524-022-00658-y. Epub 2022 Jun 10.
5
COVID-19 in Latin America and the Caribbean: Two years of the pandemic.拉丁美洲和加勒比地区的 COVID-19:疫情两年。
J Intern Med. 2022 Sep;292(3):409-427. doi: 10.1111/joim.13499. Epub 2022 Apr 22.
6
Analysis of Excess All-Cause Mortality and COVID-19 Mortality in Peru: Observational Study.秘鲁全因超额死亡率和新冠病毒疾病死亡率分析:观察性研究
Trop Med Infect Dis. 2022 Mar 5;7(3):44. doi: 10.3390/tropicalmed7030044.
7
Excess mortality associated with COVID-19 in Brazil: 2020-2021.巴西 2020-2021 年 COVID-19 相关超额死亡率。
J Public Health (Oxf). 2023 Mar 14;45(1):e7-e9. doi: 10.1093/pubmed/fdab398.
8
Analysis of Excess Mortality Data at Different Altitudes During the COVID-19 Outbreak in Ecuador.厄瓜多尔新冠疫情期间不同海拔地区超额死亡率数据分析
High Alt Med Biol. 2021 Dec;22(4):406-416. doi: 10.1089/ham.2021.0070.
9
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study.英格兰第一波和第二波大流行期间的 COVID-19 医院活动和院内死亡率:一项观察性研究。
Thorax. 2022 Nov;77(11):1113-1120. doi: 10.1136/thoraxjnl-2021-218025. Epub 2021 Nov 24.
10
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.人群中 SARS-CoV-2 的暴露水平比血清流行率调查所显示的要高得多。
PLoS Comput Biol. 2021 Sep 20;17(9):e1009436. doi: 10.1371/journal.pcbi.1009436. eCollection 2021 Sep.